Skip to main content
- Addressing MAT’s Biggest Challenge: Stigma
- Breaking Down the Harm Reduction and Addiction Treatment Divide
- Case Reviews: Clinical Scenarios in Substance Use Disorders
- Comorbid PTSD and Substance Use Disorders: Case-Based Interactive Learning
- Comorbid Substance Use and How it Influences Psychiatric Care
- Digging Deeper: Substance Use Disorder Screening in Primary Care – What to Know and When to Screen
- Engaging Primary Care Clinics to Support Use of Best Practices for Opioid Prescribing, Pain Management, and Treatment of Opioid Use Disorder
- Healing Addiction, Stress, and Pain with Mindfulness-Oriented Recovery Enhancement: A New, Evidence-Based, Neuroscience-Informed Treatment Approach
- Implementing Trauma-Informed Care in Clinical Settings
- Improving Adherence to Medications for Opioid Use Disorder to Prevent Overdose Events
- Introduction to Substance Use Disorders
- Neurobiology of Addiction: Focus on Biological Foundations of Addictions
- Pain, Special Populations, Policy, Ethical Considerations, Stigma
- Principles of Addiction Treatment
- Screening, Assessment, and Diagnosis: Focus on Identification and Evaluation
- Suicide Prevention: Working With Patients Who Have Substance Use Disorders
- Taking a Team Approach to Opioid Overdose Treatment: Facilities, Patients, and Caregivers
- The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: What It Is and How It Can Be Implemented
- The Power of Shared Decision-Making: Collaboration With Patients and Families to Support Effective Pain Management
- Voices of Recovery: Combining Medication for Opioid Use Disorders With 12-Step Recovery Support
- Xylazine in the Illicit Drug Supply: Making Overdoses Worse and More Difficult to Manage
- Xylazine Withdrawal: Managing Uncharted Territory